X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2507) 2507
Patent (1788) 1788
Book Review (395) 395
Publication (210) 210
Book Chapter (62) 62
Conference Proceeding (51) 51
Newspaper Article (27) 27
Book / eBook (16) 16
Dissertation (7) 7
Magazine Article (6) 6
Government Document (4) 4
Data Set (1) 1
Newsletter (1) 1
Reference (1) 1
Trade Publication Article (1) 1
Transcript (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (1790) 1790
hygiene (1770) 1770
human necessities (1768) 1768
medical or veterinary science (1768) 1768
radiation therapy (1741) 1741
index medicus (1739) 1739
electrotherapy (1727) 1727
magnetotherapy (1727) 1727
ultrasound therapy (1727) 1727
basic electric elements (1615) 1615
capacitors (1568) 1568
capacitors, rectifiers, detectors, switching devices orlight-sensitive devices, of the electrolytic type (1567) 1567
humans (1455) 1455
switching (1015) 1015
general tagging of cross-sectional technologies spanning over several sections of the ipc (804) 804
general tagging of new technological developments (804) 804
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (804) 804
female (747) 747
male (743) 743
technical subjects covered by former uspc (707) 707
technical subjects covered by former us classification (670) 670
middle aged (540) 540
adult (505) 505
basic electronic circuitry (404) 404
animals (367) 367
aged (346) 346
immunology (340) 340
analysis (293) 293
pharmacology & pharmacy (282) 282
patients (274) 274
therapy (274) 274
treatment outcome (270) 270
electric techniques not otherwise provided for (255) 255
casings or constructional details of electric apparatus (246) 246
manufacture of assemblages of electrical components (246) 246
printed circuits (246) 246
chemistry (245) 245
technologies or applications for mitigation or adaptation againstclimate change (215) 215
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (214) 214
metallurgy (213) 213
current collectors (207) 207
line connectors (207) 207
drug therapy (206) 206
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (205) 205
impedance networks, e.g. resonant circuits (201) 201
resonators (201) 201
cancer (200) 200
generation of noise by such circuits (200) 200
generation of oscillations, directly or by frequency-changing,by circuits employing active elements which operate in anon-switching manner (200) 200
mice (199) 199
medicine (196) 196
research (196) 196
transporting (187) 187
performing operations (186) 186
psychiatry (186) 186
research article (180) 180
care and treatment (176) 176
retrospective studies (164) 164
efficacy (160) 160
multidisciplinary sciences (160) 160
immunoglobulin class switching (159) 159
safety (157) 157
b-lymphocytes - immunology (156) 156
physics (155) 155
adolescent (152) 152
health aspects (152) 152
double-blind (150) 150
drugs (150) 150
medical research (150) 150
generation (149) 149
clinical trials (148) 148
infectious diseases (148) 148
clinical neurology (145) 145
semiconductor devices (145) 145
science (144) 144
electric solid state devices not otherwise provided for (141) 141
oncology (138) 138
conversion or distribution of electric power (136) 136
neurosciences (135) 135
young adult (134) 134
proteins (131) 131
medicine & public health (128) 128
schizophrenia (127) 127
electric communication technique (124) 124
studies (124) 124
article (123) 123
hiv (123) 123
mutation (121) 121
gene expression (115) 115
diagnosis (114) 114
expression (113) 113
cell biology (112) 112
human immunodeficiency virus--hiv (110) 110
usage (109) 109
rheumatology (107) 107
risk factors (106) 106
surgery (106) 106
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (105) 105
biology (104) 104
drug substitution (104) 104
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
OISE - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Stacks (2) 2
Law (Bora Laskin) - Stacks (1) 1
Media Commons - Microtexts (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Theses (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4239) 4239
French (556) 556
German (416) 416
Chinese (63) 63
Korean (27) 27
Japanese (25) 25
Spanish (25) 25
Russian (12) 12
Romanian (8) 8
Portuguese (5) 5
Hebrew (3) 3
Ukrainian (3) 3
Danish (2) 2
Italian (2) 2
Polish (2) 2
Swedish (2) 2
Bosnian (1) 1
Czech (1) 1
Dutch (1) 1
Hungarian (1) 1
Moldavian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, pp. e0175589 - e0175589
The safety and efficacy of carbon-ion radiotherapy for advanced non-small cell lung cancer have not been established. We evaluated the clinical outcomes and... 
SURGERY | IRRADIATION | METAANALYSIS | STEREOTACTIC BODY RADIOTHERAPY | CONCURRENT CHEMOTHERAPY | MULTIDISCIPLINARY SCIENCES | JAPAN | REGIMEN | COMBINATION | ELDERLY-PATIENTS | RADIATION-THERAPY | Carcinoma, Non-Small-Cell Lung - radiotherapy | Heavy Ion Radiotherapy - adverse effects | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Male | Survival Rate | Treatment Outcome | Photons | Pilot Projects | Aged, 80 and over | Female | Aged | Care and treatment | Patient outcomes | Research | Diagnosis | Radiotherapy | Lung cancer, Non-small cell | Health aspects | Brain | Respiratory function | Cushions | Lung cancer | Radiation | Gadolinium | Metastasis | Cancer therapies | Metastases | Computed tomography | Surgery | Immunotherapy | Tomography | Pharmaceutical industry | Dopamine D5 receptors | Medical research | Lymphatic system | Computer simulation | Patients | Ion beams | Chemotherapy | Inhibitors | Beam switching | Irradiation | Relative biological effectiveness (RBE) | Planning | Neuroimaging | Terminology | 3-Aminobutyric acid | Toxicity | Medical services | Criteria | Clinical outcomes | Ethics | Biological effects | Epidermal growth factor | Format | Dementia disorders | Dopamine D2 receptors | Heart diseases | Particle beams | Fasting | Medical imaging | Review boards | Complications | Lung diseases | Organs | Shells | Radiation therapy | Carbon | Cisplatin | Simulation | Magnetic resonance imaging | Resonance | Positron emission tomography | Elderly | Tumors | Cancer | Index Medicus
Journal Article
BMC INFECTIOUS DISEASES, ISSN 1471-2334, 09/2017, Volume 17, Issue 1, pp. 658 - 658
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2016, Volume 113, Issue 39, pp. 10962 - 10967
Journal Article
BMC INFECTIOUS DISEASES, ISSN 1471-2334, 01/2019, Volume 19, Issue 1, pp. 59 - 59
BackgroundDirect comparisons between lamivudine plus bPIs and lamivudine plus dolutegravir as maintenance strategies in virologically-suppressed HIV positive... 
INFECTIOUS DISEASES | Atazanavir | Darunavir | EMTRICITABINE | Lamivudine | OPEN-LABEL | SIMPLIFICATION | Antiretroviral therapy | NON-INFERIORITY | MAINTENANCE | HIV | Maintenance therapy | ritonavir | Dual therapy | TRIPLE THERAPY | INHIBITOR | Dolutegravir | Lamivudine - administration & dosage | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | HIV Seropositivity - drug therapy | Male | Anti-HIV Agents - administration & dosage | Lamivudine - adverse effects | Ritonavir - therapeutic use | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Tenofovir - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Treatment Outcome | Atazanavir Sulfate - therapeutic use | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Darunavir - therapeutic use | Cohort Studies | HIV Seropositivity - virology | HIV patients | Dosage and administration | Drug therapy | Patient outcomes | Antiretroviral drugs | Therapy | Renal function | Toxicity | Health risks | Durability | Lipids | Risk analysis | Patients | Cholesterol | Switching | Risk factors | Tenofovir | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Mutation | Index Medicus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 03/2017, Volume 17, Issue 1, pp. 215 - 215
Journal Article
Infection, ISSN 0300-8126, 8/2017, Volume 45, Issue 4, pp. 521 - 528
Nucleos(t)ide reverse transcriptase inhibitors (NRTI) toxicity may represent a threat for long-term success of combined antiretroviral therapy. Some studies... 
Medicine & Public Health | NRTI-sparing regimen | General Practice / Family Medicine | Efficacy | Internal Medicine | Infectious Diseases | Tolerability | Darunavir/ritonavir | Raltegravir | Antiretroviral therapy | INFECTIOUS DISEASES | MULTICENTER | SAFETY | FOLLOW-UP | HIV-1-INFECTED PATIENTS | SUPPRESSION | LAMIVUDINE | REVERSE-TRANSCRIPTASE INHIBITORS | TREATMENT SIMPLIFICATION | ACTIVE ANTIRETROVIRAL THERAPY | MITOCHONDRIAL DYSFUNCTION | Raltegravir Potassium - adverse effects | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Raltegravir Potassium - therapeutic use | Male | HIV-1 - genetics | Viral Load | Drug Therapy, Combination - adverse effects | RNA, Viral - genetics | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Italy | Darunavir - adverse effects | Darunavir - therapeutic use | Cohort Studies | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Diagnosis | Health aspects | HIV infection | Antiretroviral drugs | Therapy | RNA-directed DNA polymerase | Toxicity | Ritonavir | Regression analysis | Gender | Ribonucleic acid--RNA | Patients | Switching | CD4 antigen | Confidence intervals | Hepatitis | Protease inhibitors | Antiretroviral agents | Human immunodeficiency virus--HIV | Men | Index Medicus
Journal Article
Science, ISSN 0036-8075, 01/2017, Volume 355, Issue 6320, pp. 78 - 83
Prostate cancer relapsing from antiandrogen therapies can exhibit variant histology with altered lineage marker expression, suggesting that lineage plasticity... 
PATHWAY | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | SMALL-CELL CARCINOMA | PTEN | GENERATION | TUMORIGENESIS | EXPRESSION | DEFICIENCY | DELETION | EZH2 | Enhancer of Zeste Homolog 2 Protein - antagonists & inhibitors | Epigenesis, Genetic | Humans | SOXB1 Transcription Factors - antagonists & inhibitors | Male | Retinoblastoma-Like Protein p107 - genetics | Tumor Suppressor Protein p53 - genetics | Neoplasms, Experimental - pathology | Neoplasm Metastasis | Prostatic Neoplasms - genetics | SOXB1 Transcription Factors - genetics | Neoplasms, Experimental - genetics | Adenocarcinoma - genetics | Prostatic Neoplasms - drug therapy | Neuroendocrine Tumors - pathology | PTEN Phosphohydrolase - genetics | Prostatic Neoplasms - pathology | Enhancer of Zeste Homolog 2 Protein - genetics | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Neuroendocrine Tumors - genetics | Cell Lineage | Drug Resistance, Neoplasm - genetics | Animals | Androgen Antagonists - therapeutic use | Cell Line, Tumor | Neuroendocrine Tumors - drug therapy | Cell Plasticity | Mice | Mutation | Neoplasms, Experimental - drug therapy | Prevention | Antimitotic agents | Epigenetic inheritance | Development and progression | Genetic aspects | Dosage and administration | Metastasis | Gene expression | Antineoplastic agents | Drug resistance | Health aspects | Prostate cancer | Drugs | Therapy | Deprivation | Histology | Hormones | Suppressors | Switching | Signal transduction | Sensitivity | Androgens | Inhibitors | Rodents | Plasticity | Epigenetics | Tumor suppressor genes | Plastic properties | Prostate | Cancer | Tumors | Index Medicus | Mutations
Journal Article